Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Jason M. Redman, Jay Friedman, Yvette Robbins, Cem Sievers, Xinping Yang, Wiem Lassoued, Andrew Sinkoe, Antonios Papanicolau-Sengos, Chyi-Chia Lee, Jennifer L. Marte, Evrim Turkbey, Wojtek Mydlarz, Arjun Joshi, Nyall R. London Jr., Matthew Pierce, Rodney Taylor, Steven Hong, Andy Nguyen, Patrick Soon-Shiong, Jeffrey Schlom, James L. Gulley, Clint T. Allen
Format:	Article
Language:	English
Published:	American Society for Clinical Investigation 2023-06-01
Series:	The Journal of Clinical Investigation
Online Access:	https://doi.org/10.1172/JCI172059

Similar Items

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
by: Jason M. Redman, et al.
Published: (2023-06-01)

592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV unrelated HNSCC
by: Jeffrey Schlom, et al.
Published: (2023-11-01)

420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer
by: Ravi Madan, et al.
Published: (2021-11-01)

Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity
by: Youji Hong, et al.
Published: (2022-03-01)

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
by: Diana C. Lopez, et al.
Published: (2022-10-01)

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
by: Roy A. Mariuzza, et al.
Published: (2023-11-01)

913 Tumor immune micro-environment (TIME) Atlas for prostate cancer bone metastasis
by: James L Gulley, et al.
Published: (2023-11-01)

The neoepitope landscape of breast cancer: implications for immunotherapy
by: Pooja Narang, et al.
Published: (2019-03-01)

Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes
by: Cem Sievers, et al.
Published: (2021-12-01)

Circular RNAs as a potential source of neoepitopes in cancer
by: Jiaqi Xia, et al.
Published: (2023-04-01)

Clinical implications of neoepitope landscapes for adult and pediatric cancers
by: Yang-Yang Feng, et al.
Published: (2017-08-01)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2017-11-01)

SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
by: Yilin Ye, et al.
Published: (2023-01-01)

Neoepitope fragments as biomarkers for different phenotypes of intervertebral disc degeneration
by: Shangbin Cui, et al.
Published: (2022-09-01)

Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
by: Huahui Yu, et al.
Published: (2021-11-01)

Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
by: Lixia Wei, et al.
Published: (2020-02-01)

Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01)

Machine Learning-Enhanced T Cell Neoepitope Discovery for Immunotherapy Design
by: Joana Martins, et al.
Published: (2019-05-01)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
by: Els M. E. Verdegaal, et al.
Published: (2017-09-01)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2018-05-01)

A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations
by: Jugmohit S. Toor, et al.
Published: (2018-01-01)

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature
by: Marta Riba, et al.
Published: (2021-06-01)

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
by: Teresa Rodriguez-Calvo, et al.
Published: (2021-04-01)

Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice
by: Shen Dai, et al.
Published: (2021-09-01)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
by: Marion Arnaud, et al.
Published: (2023-01-01)

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models
by: Nadia Viborg, et al.
Published: (2023-05-01)

Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse
by: Andrea Castro, et al.
Published: (2023-08-01)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
by: Katelyn L. Donahue, et al.
Published: (2022-02-01)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
by: Jonas P. Becker, et al.
Published: (2021-04-01)

Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition
by: Andrew C. McShan, et al.
Published: (2023-12-01)

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
by: Xiangning Han, et al.
Published: (2023-06-01)

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
by: Hakimeh Ebrahimi-Nik, et al.
Published: (2021-11-01)

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
by: Michal Bassani-Sternberg, et al.
Published: (2016-11-01)

A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritis
by: Solveig Skovlund Groen, et al.
Published: (2021-12-01)

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers
by: Jeffrey Schlom, et al.
Published: (2021-11-01)

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
by: Annie Borch, et al.
Published: (2024-04-01)

Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
by: Adva Mechaly, et al.
Published: (2022-03-01)

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors
by: Lena Immisch, et al.
Published: (2023-02-01)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01)

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
by: Christopher B. Driscoll, et al.
Published: (2020-02-01)